Literature DB >> 27202487

Cost-Effectiveness and Long-Term Outcomes of Sovaldi (SOFOSBUVIR) for the Treatment of Chronic Hepatitis C Infected (HCV) Patients from a Swedish Societal Perspective.

S Cure1, I Guerra1.   

Abstract

Entities:  

Year:  2014        PMID： 27202487     DOI： 10.1016/j.jval.2014.08.2508

Source DB:  PubMed          Journal:  Value Health        ISSN： 1098-3015            Impact factor:   5.725


× No keyword cloud information.
  1 in total

Review 1.  Approaches to manage 'affordability' of high budget impact medicines in key EU countries.

Authors:  Mathias Flume; Marc Bardou; Stefano Capri; Oriol Sola-Morales; David Cunningham; Lars-Ake Levin; Maarten J Postma; Nicolas Touchot
Journal:  J Mark Access Health Policy       Date:  2018-06-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.